Toronto, Ontario–(Newsfile Corp. – November 16, 2020) – Canbud Distribution Corporation (CSE: CBDX) (“Canbud”) is pleased to provide an update on its existing progress and future initiatives.
The Company portrays itself as a science and technology company. It has developed a cost-effective outdoor hemp cultivation system including a proprietary onsite clonal system. The Company continues to work on the DNA markers to create superior cultivars.
The Company is also working on its proprietary CanbudProve platform. The platform leverages the Hyperledger Fabric network to form the backbone of integrations to the various software packages along the supply chain providing assurances for both the industrial customers as well the individual end users. The platform will also generate targeted and scientific based user experiences while addressing privacy and online security.
Additionally, the Company is currently exploring highly scalable hemp based technologies as it relates to the automotive, energy and construction sectors.
Canbud is also currently reviewing opportunities with a health and wellness theme, including organic based therapies.
Robert Tjandra, COO comments, “We had a dual priority for 2020, namely getting publicly listed and proving out our cloning and cultivation model. We have done both and are now moving forward to work on transformational opportunities that will add significant shareholder value. Being a publicly traded science and technology centric company advantageously positions Canbud to capitalize on numerous opportunities that may arise.”
The Company also announces that it has granted an aggregate of 6,050,000 options to purchase common shares of the Company exercisable at a price of $0.125 per share for a period of five years expiring on Nov 13, 2025 to directors, officers and consultants of the Company. The common shares issuable upon exercise of the options are subject to a four month and one day statutory hold period from the original date of grant.
About Canbud Distribution Corporation
Canbud Distribution Corporation is a science and technology company focused on the global hemp space inclusive of hemp cannabinoids (CBD). Currently the Company, through its subsidiaries, holds three industrial hemp licenses for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid based products on leased lands located in McKellar, Ontario, Kettleby, Ontario and Lakefield, Ontario. Each hemp licence allows the growing and harvesting of hemp CBD flowers for processing into CBD and other cannabinoids extracts.
For further information, please contact:
Robert Tjandra, President
Email: [email protected]
This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to future projects and initiatives. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to raise further capital and the Company’s ability to obtain regulatory and exchange approvals. Accordingly, readers should not place undue reliance on the forward‐looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68277